These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 38714484)
1. Trial characteristics and treatment effect estimates in randomized controlled trials of Chinese herbal medicine: A meta-epidemiological study. Wang BH; Lin YL; Gao YY; Song JL; Qin L; Li LQ; Liu WQ; Zhong CCW; Jiang MY; Mao C; Yang XB; Chung VCH; Wu IXY J Integr Med; 2024 May; 22(3):223-234. PubMed ID: 38714484 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Anglemyer A; Horvath HT; Bero L Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322 [TBL] [Abstract][Full Text] [Related]
4. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis]. Li XQ; Ling CQ Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126 [TBL] [Abstract][Full Text] [Related]
5. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study. Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786 [TBL] [Abstract][Full Text] [Related]
6. Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies. Page MJ; Higgins JP; Clayton G; Sterne JA; Hróbjartsson A; Savović J PLoS One; 2016; 11(7):e0159267. PubMed ID: 27398997 [TBL] [Abstract][Full Text] [Related]
7. Chinese herbal medicine Ginkgo biloba L. preparations for ischemic stroke: An overview of systematic reviews and meta-analyses. Meng TT; You YP; Li M; Guo JB; Song XB; Ding JY; Xie XL; Li AQ; Li SJ; Yin XJ; Wang P; Wang Z; Wang BL; He QY J Integr Med; 2024 Mar; 22(2):163-179. PubMed ID: 38519277 [TBL] [Abstract][Full Text] [Related]
8. Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population. You LZ; Dai QQ; Zhong XY; Yu DD; Cui HR; Kong YF; Zhao MZ; Zhang XY; Xu QQ; Guan ZY; Wei XX; Zhang XC; Han SJ; Liu WJ; Chen Z; Zhang XY; Zhao C; Jin YH; Shang HC J Integr Med; 2023 Sep; 21(5):441-454. PubMed ID: 37596131 [TBL] [Abstract][Full Text] [Related]
9. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292 [TBL] [Abstract][Full Text] [Related]
10. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis. Fan AY; Gu S; Alemi SF; J Integr Med; 2020 Sep; 18(5):385-394. PubMed ID: 32792254 [TBL] [Abstract][Full Text] [Related]
11. The relationship of publication language, study population, risk of bias, and treatment effects in acupuncture related systematic reviews: a meta-epidemiologic study. Li J; Hui X; Yao L; Shi A; Yan P; Yao Y; Wang Q; Ma Y; Wei D; Lan L; Chen L; Yan L; Fang F; Li H; Feng X; Wu J; Qiao Y; Zhang W; Esill J; Qiao C; Yang K BMC Med Res Methodol; 2023 Apr; 23(1):96. PubMed ID: 37081403 [TBL] [Abstract][Full Text] [Related]
12. Empirical evidence of study design biases in nutrition randomised controlled trials: a meta-epidemiological study. Stadelmaier J; Roux I; Petropoulou M; Schwingshackl L BMC Med; 2022 Oct; 20(1):330. PubMed ID: 36217133 [TBL] [Abstract][Full Text] [Related]
13. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478 [TBL] [Abstract][Full Text] [Related]
14. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome. Zhou K; Zhang J; Xu L; Wu T; Lim CE Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007535. PubMed ID: 27731904 [TBL] [Abstract][Full Text] [Related]
15. Chinese herbal medicine for endometriosis. Flower A; Liu JP; Lewith G; Little P; Li Q Cochrane Database Syst Rev; 2012 May; (5):CD006568. PubMed ID: 22592712 [TBL] [Abstract][Full Text] [Related]
16. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098 [TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
18. The Efficacy and Safety of Chinese Herbal Medicine in the Treatment of Knee Osteoarthritis: An Updated Systematic Review and Meta-Analysis of 56 Randomized Controlled Trials. Lin Z; Zheng J; Chen M; Chen J; Lin J Oxid Med Cell Longev; 2022; 2022():6887988. PubMed ID: 35035664 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Chinese Herbal Medicine for Knee Osteoarthritis: Systematic Review and Meta-analysis of Randomized Controlled Trials. Liang Y; Xu Y; Zhu Y; Ye H; Wang Q; Xu G Phytomedicine; 2022 Jun; 100():154029. PubMed ID: 35316726 [TBL] [Abstract][Full Text] [Related]
20. Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis. Wu JY; Yang JL; Hu JL; Xu S; Zhang XJ; Qian SY; Chen ML; Ali MA; Zhang J; Zha Z; Zheng GQ Front Immunol; 2024; 15():1429895. PubMed ID: 39229262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]